Veterinary MedicineImmunologyInfectious DiseasesAdaptive ImmunityImmunology Of Infectious DiseasesVaccine ImmunologyHelminth ImmunologyHost-parasite Immune InteractionsHumoral Immune ResponsesParasite AntigensParasitic Disease PathogenesisT-cell Responses To ParasitesAdult Worm BurdenAnimal Challenge ModelsAnimal Disease ModelsImmunodominant AntigensProtein Expression LevelsSecreted AntigensSecreted Protein IdentificationVaccination-induced Immunity
BACKGROUND: Trichinella spiralis infection induces protective immunity against re-infection in animal models. Identification of the antigens eliciting acquired immunity during infection is important for vaccine development against Trichinella infection and immunodiagnosis. METHODS AND FINDINGS: The T. spiralis adult cDNA library was immunoscreened with sera from pigs experimentally infected with 20,000 infective T. spiralis larvae. Total 43 positive clones encoding for 28 proteins were identified; one of the immunodominant proteins was 20 kDa Ts-ES-1 secreted by Trichinella stichocytes and existing in the excretory/secretory (ES) products of T. spiralis adult and muscle larval worms. Ts-ES-1 contains 172 amino acids with a typical signal peptide in the first 20 amino acids. The expression of Ts-ES-1 was detected in both the adult and muscle larval stages at the mRNA and protein expression levels. Mice immunized with recombinant Ts-ES-1 (rTs-ES-1) formulated with ISA50v2 adjuvant exhibited a significant worm reduction in both the adult worm (27%) and muscle larvae burden (42.1%) after a challenge with T. spiralis compared to the adjuvant control group (p<0.01). The rTs-ES-1-induced protection was associated with a high level of specific anti-Ts-ES-1 IgG antibodies and a Th1/Th2 mixed immune response. CONCLUSION: The newly identified rTs-ES-1 is an immunodominant protein secreted by Trichinella stichocytes during natural infection and enables to the induction of partial protective immunity in vaccinated mice against Trichinella infection. Therefore, rTs-ES-1 is a potential candidate for vaccine development against trichinellosis.
43
Jason Mulvenna, Brett R. Hamilton, Shivashankar H. Nagaraj et al. · Molecular & Cellular Proteomics · 2008 · 186 citations · Full text
Andrew J. Reason, Lauri A. Ellis, Judith A. Appleton et al. · Glycobiology · 1994 · 113 citations
Katharina Oeser, Christian Schwartz, David Voehringer · Mucosal Immunology · 2014 · 111 citations · Full text
Angela Williamson, Sara Lustigman, Yelena Oksov et al. · Infection and Immunity · 2006 · 111 citations · Full text